PRAXIS PRECISION MEDICINES, INC. (PRAX) P/E Ratio

Praxis Precision Medicines, Inc. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

• Praxis Precision Medicines, Inc. pe ratio for the quarter ending 2026-06-30 was -27.6, a change of -24.06 year-over-year.
• Praxis Precision Medicines, Inc. pe ratio for the quarter ending 2026-03-31 was -27.42, a change of -23.8 year-over-year.
• Praxis Precision Medicines, Inc. pe ratio for the quarter ending 2025-12-31 was -24.49, a change of -16.31 year-over-year.
• Praxis Precision Medicines, Inc. pe ratio for the quarter ending 2025-09-30 was -4.11, a change of 2.67 year-over-year.
• Praxis Precision Medicines, Inc. pe ratio for fiscal 2026 was -27.6.
• Praxis Precision Medicines, Inc. pe ratio for fiscal 2025 was -24.49, a change of -16.31 from fiscal 2024.
• Praxis Precision Medicines, Inc. pe ratio for fiscal 2024 was -8.18, a change of -6.59 from fiscal 2023.
• Praxis Precision Medicines, Inc. pe ratio for fiscal 2023 was -1.59, a change of -1.04 from fiscal 2022.